Large-scale molecular endotype discovery in synovial fluid reveals osteoarthritis as a single biological continuum

Perry TA., Deng Y., Hulley PA., Maciewicz RA., Mitchelmore J., Larsson S., Gogain J., Brachat S., Struglics A., Appleton CT., Kluzek S., Arden NK., Felson D., Bondi L., Kapoor M., Lohmander LS., Welting TJ., Walsh DA., Valdes AM., Jostins-Dean L., Watt FE., Tom BDM., Vincent TL., Perry TA., Deng Y., Hulley PA., Maciewicz RM., Kluzek S., Arden NK., Vincent TL., Batchelor V., Mackay-Alderson J., Brewer G., Marsden B., Price AJ., Goff M., Kumar V., Tey J., Szommer T., Mitchelmore J., Brachat S., Gasser J., Jennings L., Larsson S., Struglics A., Lohmander LS., Gogain J., Perry D., Mitchel A., Zepko E., Appleton CT., Birmingham TB., Klapak JD., Felson D., Bondi L., Tom BDM., Kapoor M., Gandhi R., Perruccio A., Rampersaud YR., Perry K., Welting TJ., Emans P., Boymans T., Jutten L., Caron M., Akker GVD., Walsh DA., Valdes AM., Doherty M., Georgopoulos V., Papadaki A., Williams A., Hardingham T., Kennedy S., Tambiah J., Galesso D., Giordan N., Ali W.

Abstract Knee osteoarthritis affects 40% of people during their lifetime, significantly impacting societies worldwide. Its molecular pathogenesis remains poorly understood and variable clinical phenotypes suggest it may be more than one disease. We established S ynovial fluid T o detect E ndoty p es by U nbiased P roteomics in OA (STEpUP OA) to search for molecular endotypes in knee OA synovial fluid, and to reveal key pathobiological pathways across 1361 individuals with knee OA. Using unsupervised clustering, a single cluster representing a biological continuum is observed, primarily driven by “Epithelial Mesenchymal Transition”. Distinct molecular endotypes are not detected. “Angiogenesis”, “Complement” and “Coagulation” are enriched for after stratification by clinical phenotype (obesity status, biological sex). Complement and coagulation are associated with the inflammatory marker, C-reactive protein. Associations with patient-reported knee pain are weaker. These findings support knee OA as a biological continuum, identify common and phenotype-enriched targetable pathways, and a rationale for stratification in clinical trial design.

DOI

10.1038/s41467-026-71632-4

Type

Journal article

Publisher

Springer Science and Business Media LLC

Publication Date

2026-06-02T00:00:00+00:00

Volume

17

Permalink More information Close